These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 27181110)

  • 1. Pitavastatin improves glycated hemoglobin in patients with poorly controlled type 2 diabetes.
    Huang CH; Huang YY; Hsu BR
    J Diabetes Investig; 2016 Sep; 7(5):769-76. PubMed ID: 27181110
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Do Statins Counteract the Effect of Antidiabetic Drugs? Results of the SCEAD Study.
    Tarim BA; Fici F; Tengiz I; Avunduk S; Ozcan Y; Faikoglu G; Ari E; Robles NR; Grassi G
    Yonsei Med J; 2023 Mar; 64(3):175-180. PubMed ID: 36825343
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pitavastatin: clinical effects from the LIVES Study.
    Teramoto T
    Atheroscler Suppl; 2011 Nov; 12(3):285-8. PubMed ID: 22152283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Forty-eight weeks of statin therapy for type 2 diabetes mellitus patients with lower extremity atherosclerotic disease: Comparison of the effects of pitavastatin and atorvastatin on lower femoral total plaque areas.
    Zhou X; Wu L; Chen Y; Xiao H; Huang X; Li Y; Xiao H; Cao X
    J Diabetes Investig; 2021 Jul; 12(7):1278-1286. PubMed ID: 33289308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A 52-week, randomized, open-label, parallel-group comparison of the tolerability and effects of pitavastatin and atorvastatin on high-density lipoprotein cholesterol levels and glucose metabolism in Japanese patients with elevated levels of low-density lipoprotein cholesterol and glucose intolerance.
    Sasaki J; Ikeda Y; Kuribayashi T; Kajiwara K; Biro S; Yamamoto K; Ageta M; Kobori S; Saikawa T; Otonari T; Kono S
    Clin Ther; 2008 Jun; 30(6):1089-101. PubMed ID: 18640465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Are all statins the same? Focus on the efficacy and tolerability of pitavastatin.
    da Silva PM
    Am J Cardiovasc Drugs; 2011; 11(2):93-107. PubMed ID: 21446776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of pitavastatin and atorvastatin on regression of atherosclerosis assessed using intravascular ultrasound: a meta-analysis.
    Liu H; Zhang M; Li D; Tian J; Wang X; Pan J; Liu D; Li X; An F
    Coron Artery Dis; 2018 Sep; 29(6):459-468. PubMed ID: 29738341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Multi-Center, Open-Label, Two-Arm Parallel Group Non-inferiority Randomized Controlled Trial Evaluating the Effect of Pitavastatin, Compared to Atorvastatin, on Glucose Metabolism in Prediabetics with Hypertension and Dyslipidemia: Rationale and Design for the China Hemoglobin A1c Metabolism Protection Union Study (CAMPUS).
    Zhang J; Shao Y; Liu Y; Tao J
    Cardiovasc Drugs Ther; 2018 Dec; 32(6):581-589. PubMed ID: 30187345
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distinct effects of pitavastatin and atorvastatin on lipoprotein subclasses in patients with Type 2 diabetes mellitus.
    Shimabukuro M; Higa M; Tanaka H; Shimabukuro T; Yamakawa K; Masuzaki H
    Diabet Med; 2011 Jul; 28(7):856-64. PubMed ID: 21244474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative long-term efficacy and tolerability of pitavastatin 4 mg and atorvastatin 20-40 mg in patients with type 2 diabetes mellitus and combined (mixed) dyslipidaemia.
    Gumprecht J; Gosho M; Budinski D; Hounslow N
    Diabetes Obes Metab; 2011 Nov; 13(11):1047-55. PubMed ID: 21812889
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pitavastatin and Atorvastatin double-blind randomized comPArative study among hiGh-risk patients, including thOse with Type 2 diabetes mellitus, in Taiwan (PAPAGO-T Study).
    Liu PY; Lin LY; Lin HJ; Hsia CH; Hung YR; Yeh HI; Wu TC; Chen JY; Chien KL; Chen JW
    PLoS One; 2013; 8(10):e76298. PubMed ID: 24098467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation between adiponectin and reduction of cell adhesion molecules after pitavastatin treatment in hyperlipidemic patients with type 2 diabetes mellitus.
    Nomura S; Shouzu A; Omoto S; Inami N; Tanaka A; Nanba M; Shouda Y; Takahashi N; Kimura Y; Iwasaka T
    Thromb Res; 2008; 122(1):39-45. PubMed ID: 17920663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of pitavastatin, eicosapentaenoic acid and combined therapy on platelet-derived microparticles and adiponectin in hyperlipidemic, diabetic patients.
    Nomura S; Inami N; Shouzu A; Omoto S; Kimura Y; Takahashi N; Tanaka A; Urase F; Maeda Y; Ohtani H; Iwasaka T
    Platelets; 2009 Feb; 20(1):16-22. PubMed ID: 19172517
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the efficacy and tolerability of pitavastatin and atorvastatin: an 8-week, multicenter, randomized, open-label, dose-titration study in Korean patients with hypercholesterolemia.
    Lee SH; Chung N; Kwan J; Kim DI; Kim WH; Kim CJ; Kim HS; Park SH; Seo HS; Shin DG; Shin YW; Shim WJ; Ahn TH; Ho Yun K; Yoon MH; Cha KS; Choi SW; Han SW; Hyon MS
    Clin Ther; 2007 Nov; 29(11):2365-73. PubMed ID: 18158077
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of pitavastatin on glucose tolerance in patients with type 2 diabetes mellitus.
    Yamakawa T; Takano T; Tanaka S; Kadonosono K; Terauchi Y
    J Atheroscler Thromb; 2008 Oct; 15(5):269-75. PubMed ID: 18981652
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glucagon-like peptide-1 receptor agonists reduced the low-density lipoprotein cholesterol in Japanese patients with type 2 diabetes mellitus treated with statins.
    Hasegawa Y; Hori M; Nakagami T; Harada-Shiba M; Uchigata Y
    J Clin Lipidol; 2018; 12(1):62-69.e1. PubMed ID: 29217412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Statin therapy on glycemic control in type 2 diabetic patients: A network meta-analysis.
    Cui JY; Zhou RR; Han S; Wang TS; Wang LQ; Xie XH
    J Clin Pharm Ther; 2018 Aug; 43(4):556-570. PubMed ID: 29733433
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pitavastatin: novel effects on lipid parameters.
    Chapman MJ
    Atheroscler Suppl; 2011 Nov; 12(3):277-84. PubMed ID: 22152282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concomitant reduction in low-density lipoprotein cholesterol and glycated hemoglobin with colesevelam hydrochloride in patients with type 2 diabetes: a pooled analysis.
    Jialal I; Abby SL; Misir S; Nagendran S
    Metab Syndr Relat Disord; 2009 Jun; 7(3):255-8. PubMed ID: 19344229
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glucose-lowering effect of colestimide is associated with baseline HbA1c in type 2 diabetic patients with hypercholesterolemia.
    Yamakawa T; Kaneko T; Shigematu E; Kawaguchi J; Kadonosono K; Morita S; Terauchi Y
    Endocr J; 2011; 58(3):185-91. PubMed ID: 21350303
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.